QQQ   317.89 (+0.70%)
AAPL   162.76 (+0.25%)
MSFT   283.94 (-0.04%)
META   210.08 (+1.08%)
GOOGL   102.48 (+1.58%)
AMZN   102.88 (+0.86%)
TSLA   201.45 (+3.16%)
NVDA   274.51 (+0.25%)
NIO   10.49 (+0.29%)
BABA   101.97 (-1.36%)
AMD   96.85 (-1.05%)
T   19.09 (+0.05%)
F   12.43 (+1.14%)
MU   61.11 (-3.14%)
CGC   1.76 (+0.00%)
GE   94.98 (+0.99%)
DIS   98.95 (+0.87%)
AMC   5.02 (+1.01%)
PFE   40.51 (+0.32%)
PYPL   75.00 (+0.82%)
NFLX   340.66 (+0.66%)
QQQ   317.89 (+0.70%)
AAPL   162.76 (+0.25%)
MSFT   283.94 (-0.04%)
META   210.08 (+1.08%)
GOOGL   102.48 (+1.58%)
AMZN   102.88 (+0.86%)
TSLA   201.45 (+3.16%)
NVDA   274.51 (+0.25%)
NIO   10.49 (+0.29%)
BABA   101.97 (-1.36%)
AMD   96.85 (-1.05%)
T   19.09 (+0.05%)
F   12.43 (+1.14%)
MU   61.11 (-3.14%)
CGC   1.76 (+0.00%)
GE   94.98 (+0.99%)
DIS   98.95 (+0.87%)
AMC   5.02 (+1.01%)
PFE   40.51 (+0.32%)
PYPL   75.00 (+0.82%)
NFLX   340.66 (+0.66%)
QQQ   317.89 (+0.70%)
AAPL   162.76 (+0.25%)
MSFT   283.94 (-0.04%)
META   210.08 (+1.08%)
GOOGL   102.48 (+1.58%)
AMZN   102.88 (+0.86%)
TSLA   201.45 (+3.16%)
NVDA   274.51 (+0.25%)
NIO   10.49 (+0.29%)
BABA   101.97 (-1.36%)
AMD   96.85 (-1.05%)
T   19.09 (+0.05%)
F   12.43 (+1.14%)
MU   61.11 (-3.14%)
CGC   1.76 (+0.00%)
GE   94.98 (+0.99%)
DIS   98.95 (+0.87%)
AMC   5.02 (+1.01%)
PFE   40.51 (+0.32%)
PYPL   75.00 (+0.82%)
NFLX   340.66 (+0.66%)
QQQ   317.89 (+0.70%)
AAPL   162.76 (+0.25%)
MSFT   283.94 (-0.04%)
META   210.08 (+1.08%)
GOOGL   102.48 (+1.58%)
AMZN   102.88 (+0.86%)
TSLA   201.45 (+3.16%)
NVDA   274.51 (+0.25%)
NIO   10.49 (+0.29%)
BABA   101.97 (-1.36%)
AMD   96.85 (-1.05%)
T   19.09 (+0.05%)
F   12.43 (+1.14%)
MU   61.11 (-3.14%)
CGC   1.76 (+0.00%)
GE   94.98 (+0.99%)
DIS   98.95 (+0.87%)
AMC   5.02 (+1.01%)
PFE   40.51 (+0.32%)
PYPL   75.00 (+0.82%)
NFLX   340.66 (+0.66%)
NASDAQ:ABMD

Abiomed ESG Rating & Sustainability Data

Notice: This company has been marked as potentially delisted and may not be actively trading.
Add
Compare
Today's Range
$381.02
$381.02
50-Day Range
$377.20
$381.30
52-Week Range
$219.85
$381.99
Volume
258 shs
Average Volume
611,028 shs
Market Capitalization
$17.18 billion
P/E Ratio
65.47
Dividend Yield
N/A
Price Target
$355.60

Key ESG Takeaways for Abiomed

The keytakeaways are AI-generated and highlight the main contributors behind the net impact scores of Abiomed. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Abiomed seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is false driven by its Mechanical circulatory support devices product.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The negative contribution in the impact category is driven by its Mechanical circulatory support devices product.

ABMD Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+62.8%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+66.1%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+51.6%
Society First
Value set that emphasizes society impacts over other impacts.
+24.1%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+49.0%
Health First
Value set that emphasizes health impacts over other impacts.
+80.6%

Abiomed ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+0.89
+0.89
+1.67
+1.67
+0.07
+0.07
-0.00
+0.00
+0.00
-0.00
+0.00
+0.01
0.00
+0.00
+0.02
+0.02
-0.00
+0.01
+0.01
-1.15
-1.15
-0.41
+2.58
+2.99
-0.00
+0.30
+0.30
0.00
+0.00
-0.01
+0.01
+0.01
-0.00
+0.39
+0.39
-0.34
-0.34
+0.00
-0.01
-0.01
+0.00
-0.00
0.00
+0.00
-0.01
-0.01
+0.00
-0.43
-0.43
+0.00

Upright Model Version 0.4.0
ESG Data Last Updated: April 1, 2022

About Upright's Net Impact Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.













Abiomed ESG Rating - Frequently Asked Questions

How is Abiomed doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Abiomed has a net impact ratio of 62.8%, indicating an overall positive sustainability impact. Abiomed seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Jobs. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Scarce human capital, Waste, and Physical diseases. Learn more on the sustainability of Abiomed.

This page (NASDAQ:ABMD) was last updated on 3/31/2023 by MarketBeat.com Staff